Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05512208
Title A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib (DURAFAK)
Acronym DURAFAK
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors University of Oklahoma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of New Mexico Comprehensive Cancer Center RECRUITING Albuquerque New Mexico 87131 United States Details
Stephenson Cancer Center RECRUITING Oklahoma City Oklahoma 73117 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field